- Home
- NBIX vs KEP Comparison
NBIX vs KEP Comparison
Compare NBIX & KEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- KEP
- Stock Information
- Founded
- NBIX 1992
- KEP 1961
- Country
- NBIX United States
- KEP South Korea
- Employees
- NBIX N/A
- KEP N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- KEP Electric Utilities: Central
- Sector
- NBIX Health Care
- KEP Utilities
- Exchange
- NBIX Nasdaq
- KEP Nasdaq
- Market Cap
- NBIX 12.2B
- KEP 13.3B
- IPO Year
- NBIX 1996
- KEP N/A
- Fundamental
- Price
- NBIX $128.00
- KEP $13.73
- Analyst Decision
- NBIX Strong Buy
- KEP
- Analyst Count
- NBIX 20
- KEP 0
- Target Price
- NBIX $163.20
- KEP N/A
- AVG Volume (30 Days)
- NBIX 879.2K
- KEP 861.9K
- Earning Date
- NBIX 07-31-2025
- KEP 07-11-2025
- Dividend Yield
- NBIX N/A
- KEP 0.35%
- EPS Growth
- NBIX N/A
- KEP 667.18
- EPS
- NBIX 2.96
- KEP 5.56
- Revenue
- NBIX $2,412,600,000.00
- KEP $64,053,841,898.00
- Revenue This Year
- NBIX $16.29
- KEP $5.65
- Revenue Next Year
- NBIX $15.08
- KEP $2.21
- P/E Ratio
- NBIX $42.50
- KEP $5.04
- Revenue Growth
- NBIX 21.73
- KEP 4.91
- 52 Week Low
- NBIX $84.23
- KEP $6.68
- 52 Week High
- NBIX $157.98
- KEP $14.79
- Technical
- Relative Strength Index (RSI)
- NBIX 62.53
- KEP 69.45
- Support Level
- NBIX $125.02
- KEP $13.93
- Resistance Level
- NBIX $128.66
- KEP $14.79
- Average True Range (ATR)
- NBIX 2.68
- KEP 0.26
- MACD
- NBIX -0.34
- KEP 0.33
- Stochastic Oscillator
- NBIX 80.79
- KEP 80.68
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About KEP Korea Electric Power Corporation
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.